La última palabra en dosis mínima

Nenhuma Miniatura disponível

Data

2005-07-01

Autores

Orientador

Coorientador

Pós-graduação

Curso de graduação

Título da Revista

ISSN da Revista

Título de Volume

Editor

Tipo

Resenha

Direito de acesso

Acesso restrito

Resumo

In this article we rewiewed the indications of the low-dose hormone replacement therapy in post menopausal women. We evaluate the effects of this therapy on menopausal symptoms bone metabolism, cardiovascular risk and endometrial cancer. The low-dose hormone replacement therapy is satisfactory to relief menopausal symptoms and improves lipid profile preventing atherosclerosis. It does not increase the risk of hyperplasia or endometrial cancer when is associate with progestagens. The low dose hormone replacement therapy is also associate to improve bone mineral density but to have better comprehension about the effective action of the low dose hormone replacement therapy on bone, more studies evaluating the risk of fractures are necessary.

Descrição

Palavras-chave

Bone metabolism , Cardiovascular risk , Endometrial cancer , Low dose , Menopausal symptoms , gestagen , atherosclerosis , bone metabolism , cardiovascular risk , endometrium cancer , hormonal therapy , human , hyperplasia , low drug dose , menopausal syndrome , postmenopause , review

Idioma

Espanhol

Como citar

Revista Iberoamericana de Revisiones en Menopausia, v. 7, n. 3, p. 13-19, 2005.

URI

http://hdl.handle.net/11449/68336

Itens relacionados

Financiadores

Coleções

Artigos - Ginecologia e Obstetrícia - FMB